Comparison

B4GALNT2 Peptide - N-terminal region (AAP67019)

Item no. AAP67019
Manufacturer AVIVA Systems Biology
Amount 100ug
Category
Type Peptides
Format Lyophilized powder
Applications WB
Specific against Human (Homo sapiens)
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias B4GALT, GALGT2, MGC142235, MGC142237
Similar products B4GALNT2
Available
Description
This is a synthetic peptide designed for use in combination with anti-B4GALNT2 Antibody (ARP67019_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Gene symbol
B4GALNT2
Protein size
566
Molecular weight
62kDa
Product format
Lyophilized powder
Gene id
124872
Reconstitution and storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20C. Avoid repeat freeze-thaw cycles.
Description of target
B4GALNT2 catalyzes the last step in the biosynthesis of the human Sd(a) antigen through the addition of an N-acetylgalactosamine residue via a beta-1, 4 linkage to a subterminal galactose residue substituted with an alpha-2, 3-linked sialic acid. B4GALNT2 also catalyzes the last step in the biosynthesis of the Cad antigen.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 100ug
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close